Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akseli Hemminki

Showing results (51-60 of 280) with videos related to

Pageof 28
Sort By:
Cancer Medicine|February 27, 2023
Survival in gastric and esophageal cancers in the Nordic countries through a half centuryKari Hemminki, Filip Tichanek, Asta Försti, et al.
Cancers|August 26, 2023
Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of ImprovementsFrantisek Zitricky, Asta Försti, Akseli Hemminki, et al.
Cancer Epidemiology|September 7, 2023
Steady survival improvements in soft tissue and bone sarcoma in the Nordic countries through 50 yearsFilip Tichanek, Asta Försti, Otto Hemminki, et al.
BMC Cancer|January 30, 2013
Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancerMatias Riihimäki, Hauke Thomsen, Akseli Hemminki, et al.
International Journal of Cancer|December 23, 2016
Concordant and discordant familial cancer: Familial risks, proportions and population impactChristoph Frank, Jan Sundquist, Hongyao Yu, et al.
International Journal of Cancer|February 25, 2022
Long-term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to ThorotrastKari Hemminki, Asta Försti, Otto Hemminki, et al.
JHEP Reports : Innovation in Hepatology|November 10, 2022
Long-term survival trends for primary liver and pancreatic cancers in the Nordic countriesKari Hemminki, Asta Försti, Otto Hemminki, et al.
Obstetrics and Gynecology International|July 17, 2023
Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic CountriesFilip Tichanek, Asta Försti, Otto Hemminki, et al.
Current Cancer Drug Targets|May 4, 2017
Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune SystemVincenzo Cerullo, Cristian Capasso, Markus Vaha-Koskela, et al.
Hereditary Cancer in Clinical Practice|February 22, 2025
Age-specific familial risks in cancer as clues to germline genetic and environmental causes: focus on colorectal, endometrial, prostate, kidney, breast and lung cancersKari Hemminki, Asta Försti, Otto Hemminki, et al.
Pageof 28

Showing results (51-60 of 280) with videos related to

Sort By:
Pageof 28
Cancer Medicine|February 27, 2023
Survival in gastric and esophageal cancers in the Nordic countries through a half centuryKari Hemminki, Filip Tichanek, Asta Försti, et al.
Cancers|August 26, 2023
Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of ImprovementsFrantisek Zitricky, Asta Försti, Akseli Hemminki, et al.
Cancer Epidemiology|September 7, 2023
Steady survival improvements in soft tissue and bone sarcoma in the Nordic countries through 50 yearsFilip Tichanek, Asta Försti, Otto Hemminki, et al.
BMC Cancer|January 30, 2013
Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancerMatias Riihimäki, Hauke Thomsen, Akseli Hemminki, et al.
International Journal of Cancer|December 23, 2016
Concordant and discordant familial cancer: Familial risks, proportions and population impactChristoph Frank, Jan Sundquist, Hongyao Yu, et al.
International Journal of Cancer|February 25, 2022
Long-term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to ThorotrastKari Hemminki, Asta Försti, Otto Hemminki, et al.
JHEP Reports : Innovation in Hepatology|November 10, 2022
Long-term survival trends for primary liver and pancreatic cancers in the Nordic countriesKari Hemminki, Asta Försti, Otto Hemminki, et al.
Obstetrics and Gynecology International|July 17, 2023
Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic CountriesFilip Tichanek, Asta Försti, Otto Hemminki, et al.
Current Cancer Drug Targets|May 4, 2017
Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune SystemVincenzo Cerullo, Cristian Capasso, Markus Vaha-Koskela, et al.
Hereditary Cancer in Clinical Practice|February 22, 2025
Age-specific familial risks in cancer as clues to germline genetic and environmental causes: focus on colorectal, endometrial, prostate, kidney, breast and lung cancersKari Hemminki, Asta Försti, Otto Hemminki, et al.
Pageof 28